✦ LIBER ✦
1223 NO EARLY VIROLOGIC BREAKTHROUGH OBSERVED WITH THE HCV NS3 PROTEASE INHIBITOR BMS-650032 IN MULTIPLE DOSE MONOTHERAPY STUDIES AND PHASE 2A COMBINATION STUDIES WITH PEGIFNα/RBV
✍ Scribed by McPhee, F.; Sheaffer, A.; Yu, F.; Lee, M.; Chaniewski, S.; Falk, P.; Pasquinelli, C.; Llasamo, C.; Hughes, E.; Hernandez, D.
- Book ID
- 123359869
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 41 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.